Silvia de Sanjosé
Researcher at ISGlobal and consultant for Médecins Sans Frontières (MSF)
Does the press release accurately reflect the study?
“I would add that the study broadens the assessment to include other factors not previously considered, and in particular, HIV.”
Is the study of good quality? Are the conclusions supported by robust data?
“It is a robust study based on many years of systematic review of the literature, which updates and expands on previously published information.”
How does this study fit in with existing evidence?
“It significantly increases the contribution of infections as a cause of cancer.”
Have the authors taken confounding factors into account? Are there any important limitations to bear in mind?
“The authors are careful to set out the limitations of this study, but their conclusions are well-founded.”
What are the real-world implications?
“Having this evidence at a global level helps to strengthen vaccination programmes against agents with carcinogenic potential, such as HPV and hepatitis; to further promote the diagnosis of diseases with oncogenic potential, such as H. pylori; to work on HIV control programmes; and to stimulate research to develop new vaccines.”